Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Thoracic Surgery

Free Subscription Articles published in Eur Heart J Retrieve available abstracts of 140 articles: HTML format

Single Articles

October 2025
1. DE SILVA R, Cheng K, Henry TD, Perera D, et al
   Refractory angina: mechanisms and stratified treatment in obstructive and non-obstructive chronic myocardial ischaemic syndromes.
   Eur Heart J. 2025;46:3738-3757.
   PubMed     Abstract available
   
   
   September 2025
2. GOULD KL, Johnson NP, Roby AE, Kirkeeide R, et al
   Optimal medical care and coronary flow capacity-guided myocardial revascularization vs usual care for chronic coronary artery disease: the CENTURY trial.
   Eur Heart J. 2025;46:3273-3286.
   PubMed     Abstract available
   
   
   August 2025
3. KANG DY, Wee SB, Ahn JM, Park H, et al
   Temporal modulation of antiplatelet therapy in high-risk patients undergoing complex percutaneous coronary intervention: the TAILORED-CHIP randomized clinical trial.
   Eur Heart J. 2025 Aug 31:ehaf652. doi: 10.1093.
   PubMed     Abstract available
   
   
   
4. SANDNER S, Gaudino M, Agewall S, Bonalumi G, et al
   Antithrombotic therapy after coronary artery bypass graft surgery: a Clinical Consensus Statement of the ESC Working Group on Cardiovascular Surgery, the ESC Working Group on Cardiovascular Pharmacotherapy, and the European Association for Cardio-Thor
   Eur Heart J. 2025 Aug 30:ehaf423. doi: 10.1093.
   PubMed     Abstract available
   
   
   
5. HARADA S, Demir OM, Mitomo S
   Coronary stent migration after bailout stenting in type A acute aortic dissection: the impact of haematoma absorption.
   Eur Heart J. 2025 Aug 29:ehaf468. doi: 10.1093.
   PubMed    
   
   
   
6. BENA NNANG JY, Tembi TBT, Fodop SGJ, Mekontso JGK, et al
   Discontinuation of renin-angiotensin system inhibitors before non-cardiac surgery: a meta-analysis.
   Eur Heart J. 2025 Aug 29:ehaf573. doi: 10.1093.
   PubMed     Abstract available
   
   
   
7. VAN BELLE E, Parma R, Teles RC, Saia F, et al
   Atlas of interventional cardiology 2023: European Society of Cardiology and European Association of Percutaneous Coronary Interventions.
   Eur Heart J. 2025 Aug 29:ehaf698. doi: 10.1093.
   PubMed     Abstract available
   
   
   
8. CREA F
   Novel light on the many facets of myocardial revascularization: optical coherence tomography for calcified lesions, physiological stenosis assessment, residual risk assessment, preventive percutaneous coronary intervention, and preventive pericardioto
   Eur Heart J. 2025;46:3135-3139.
   PubMed    
   
   
   
9. GUALANDRO DM, Masip J, Halvorsen S, Price S, et al
   Acute heart failure in non-cardiac surgery.
   Eur Heart J. 2025 Aug 21:ehaf559. doi: 10.1093.
   PubMed     Abstract available
   
   
   
10. MANGIACAPRA F, Paolucci L, De Bruyne B, Rioufol G, et al
    Fractional flow reserve vs angiography to guide percutaneous coronary intervention: an individual patient data meta-analysis.
    Eur Heart J. 2025 Aug 20:ehaf504. doi: 10.1093.
    PubMed     Abstract available
    
    
    
11. ERLINGE D, Koul S
    With a little HELP from heparin at first medical contact before primary percutaneous coronary intervention.
    Eur Heart J. 2025 Aug 6:ehaf562. doi: 10.1093.
    PubMed    
    
    
    
12. GALLI M, Patrono C
    Weekly Journal Scan: can an individual participant data meta-analysis support a practice change in long-term antiplatelet therapy after percutaneous coronary intervention?
    Eur Heart J. 2025 Aug 1:ehaf532. doi: 10.1093.
    PubMed    
    
    
    
13. VALGIMIGLI M, Landi A
    Radial access for percutaneous coronary intervention: the good, the better, and the ugly.
    Eur Heart J. 2025 Aug 1:ehaf424. doi: 10.1093.
    PubMed    
    
    
    
14. CHEN J, Xu C, Qiu L, Li B, et al
    Heparin administration at first medical contact vs immediately before primary percutaneous coronary intervention: the HELP-PCI trial.
    Eur Heart J. 2025 Aug 1:ehaf481. doi: 10.1093.
    PubMed     Abstract available
    
    
    July 2025
15. OCCHIPINTI G, Laudani C, Galli M, Ortega-Paz L, et al
    Sex differences in dual antiplatelet therapy de-escalation strategies after percutaneous coronary intervention: a network meta-analysis.
    Eur Heart J. 2025 Jul 11:ehaf473. doi: 10.1093.
    PubMed     Abstract available
    
    
    
16. ALHAKAK A, Butt JH, Havers-Borgersen E, Ostergaard L, et al
    Mitral valve replacement or repair and long-term risk of infective endocarditis: a Danish nationwide study.
    Eur Heart J. 2025 Jul 11:ehaf342. doi: 10.1093.
    PubMed     Abstract available
    
    
    
17. GIACOPPO D
    Unveiling the risk of infective endocarditis after mitral valve replacement and mitral valve repair.
    Eur Heart J. 2025 Jul 11:ehaf099. doi: 10.1093.
    PubMed    
    
    
    
18. FEZZI S, Scheller B, Cortese B, Alfonso F, et al
    Definitions and standardized endpoints for the use of drug-coated balloon in coronary artery disease: consensus document of the Drug Coated Balloon Academic Research Consortium.
    Eur Heart J. 2025;46:2498-2519.
    PubMed     Abstract available
    
    
    
19. FAZEL R, Rao SV, Cohen DJ, Secemsky EA, et al
    Radial vs femoral access for percutaneous coronary intervention: temporal trends and outcomes in the USA.
    Eur Heart J. 2025 Jul 4:ehaf426. doi: 10.1093.
    PubMed     Abstract available
    
    
    
20. BLITZER D, Meinrenken CJ, Apelgren NB, Chavez XS, et al
    Carbon emission analysis of aortic valve replacement: the environmental footprint of transcatheter vs. surgical procedures.
    Eur Heart J. 2025 Jul 2:ehaf379. doi: 10.1093.
    PubMed     Abstract available
    
    
    June 2025
21. JIANG L, Li Y, Yang ZG
    Azygos vein steal syndrome after Glenn procedure in a rare single atrium-single ventricle: computed tomography insights in management of palliative cardiac surgery.
    Eur Heart J. 2025 Jun 27:ehaf436. doi: 10.1093.
    PubMed    
    
    
    
22. ZEDER K, Mak S, Galie N, Rosenkranz S, et al
    Right heart catheterization in heart failure: indications, interpretation, and pitfalls.
    Eur Heart J. 2025 Jun 16:ehaf322. doi: 10.1093.
    PubMed     Abstract available
    
    
    
23. RYAN M, Petrie MC, Kontopantelis E, Dodd M, et al
    Medical therapy and outcomes in REVIVED-BCIS2 and STICHES: an individual patient data analysis.
    Eur Heart J. 2025;46:2052-2062.
    PubMed     Abstract available
    
    
    
24. 
    Correction to: Multiple arterial vs. single arterial coronary artery bypass grafting: sex-related differences in outcomes.
    Eur Heart J. 2025 Jun 6:ehaf377. doi: 10.1093.
    PubMed    
    
    
    
25. ALI ZA, Shin D, Vijayvergiya R, Gawalkar AA, et al
    Optical coherence tomography- vs angiography-guided coronary stent implantation in calcified lesions: the ILUMIEN IV trial.
    Eur Heart J. 2025 Jun 5:ehaf331. doi: 10.1093.
    PubMed     Abstract available
    
    
    
26. BELMONTE M, Barbato E
    Mastering percutaneous coronary intervention in calcified coronary lesions with optical coherence tomography: the path to optimal outcomes.
    Eur Heart J. 2025 Jun 5:ehaf302. doi: 10.1093.
    PubMed    
    
    
    
27. KOLH P, Tchana-Sato V, Schwann TA
    Physiological stenosis assessment for coronary artery surgery: quo vadis?
    Eur Heart J. 2025 Jun 3:ehaf318. doi: 10.1093.
    PubMed    
    
    
    
28. NITSCHE C, Dobner S, Rosenblum HR, Patel KP, et al
    Cardiac transthyretin amyloidosis treatment improves outcomes after aortic valve replacement for severe stenosis.
    Eur Heart J. 2025 Jun 2:ehaf362. doi: 10.1093.
    PubMed     Abstract available
    
    
    May 2025
29. KIM MC, Park SJ, Park DW, Ahn JM, et al
    Preventive percutaneous coronary intervention for non-flow-limiting vulnerable atherosclerotic coronary plaques in diabetes: the PREVENT trial.
    Eur Heart J. 2025 May 29:ehaf273. doi: 10.1093.
    PubMed     Abstract available
    
    
    
30. GAUDINO M, Harik L, Redfors B, Leith J, et al
    Posterior left pericardiotomy in cardiac surgery and outcomes: PALACS-EF trial extended follow-up.
    Eur Heart J. 2025 May 22:ehaf325. doi: 10.1093.
    PubMed    
    
    
    
31. MONTANARO C, Arvanitaki A, Kerrigan W, Kadani Z, et al
    The Fontan Adult Brompton clinical score and mortality risk.
    Eur Heart J. 2025;46:1933-1945.
    PubMed     Abstract available
    
    
    
32. LEONE AM, Vergallo R
    Weekly Journal Scan: The five-year follow-up of FAME 3 keeps open the never-ending debate about coronary artery bypass grafting vs percutaneous coronary intervention in patients with three-vessel disease.
    Eur Heart J. 2025 May 21:ehaf345. doi: 10.1093.
    PubMed    
    
    
    
33. HANSSON EC, Omerovic E, Venetsanos D, Alfredsson J, et al
    Coronary artery bypass grafting with or without preoperative physiological stenosis assessment: a SWEDEHEART study.
    Eur Heart J. 2025 May 16:ehaf327. doi: 10.1093.
    PubMed     Abstract available
    
    
    
34. BARBANTI M, Costa G, Windecker S, Maisano F, et al
    Bicuspid aortic valve disease: advancements and challenges of transcatheter aortic valve implantation.
    Eur Heart J. 2025 May 9:ehaf307. doi: 10.1093.
    PubMed     Abstract available
    
    
    
35. FEZZI S, Giacoppo D, Fahrni G, Latib A, et al
    Individual patient data meta-analysis of paclitaxel-coated balloons vs. drug-eluting stents for small-vessel coronary artery disease: the ANDROMEDA study.
    Eur Heart J. 2025;46:1586-1599.
    PubMed     Abstract available
    
    
    
36. GALLI M, Patrono C
    Weekly Journal Scan: is a SMART-CHOICE of clopidogrel monotherapy after coronary stenting supported by adequate evidence?
    Eur Heart J. 2025 May 2:ehaf290. doi: 10.1093.
    PubMed    
    
    
    April 2025
37. KRUGER N, Fuse K, Seeger JD
    Challenges in comparing coronary artery bypass grafting vs percutaneous coronary intervention: methodological considerations for propensity score analysis.
    Eur Heart J. 2025 Apr 25:ehaf234. doi: 10.1093.
    PubMed    
    
    
    
38. BLOOM JE, Vogrin S, Chan W
    Performing risk adjustment in observational datasets to compare coronary artery bypass grafting vs percutaneous coronary intervention in patients with left ventricular systolic dysfunction.
    Eur Heart J. 2025 Apr 25:ehaf235. doi: 10.1093.
    PubMed    
    
    
    
39. LODIN K, Da Silva CO, Wang Gottlieb A, Bulatovic I, et al
    Mitral annular disjunction and mitral valve prolapse: long-term risk of ventricular arrhythmias after surgery.
    Eur Heart J. 2025 Apr 15:ehaf195. doi: 10.1093.
    PubMed     Abstract available
    
    
    
40. ZITO F, Rhellab R, de Keijzer AR
    Patient-prosthesis mismatch after aortic valve replacement: one size does not fit all.
    Eur Heart J. 2025 Apr 10:ehaf200. doi: 10.1093.
    PubMed    
    
    
    
41. BAY B, Tanner R, Gao M, Oliva A, et al
    Residual cholesterol and inflammatory risk in statin-treated patients undergoing percutaneous coronary interventiondagger.
    Eur Heart J. 2025 Apr 10:ehaf196. doi: 10.1093.
    PubMed     Abstract available
    
    
    
42. TCHETCHE D, Pibarot P, Bax JJ, Bonaros N, et al
    Transcatheter vs. surgical aortic valve replacement in women: the RHEIA trial.
    Eur Heart J. 2025 Apr 2:ehaf133. doi: 10.1093.
    PubMed     Abstract available
    
    
    March 2025
43. BUSCHER A, Plagwitz L, Yildirim K, Brix TJ, et al
    Deep Learning Electrocardiogram Model for Risk Stratification of Coronary Revascularization Need in the Emergency Department.
    Eur Heart J. 2025 Mar 29:ehaf254. doi: 10.1093.
    PubMed     Abstract available
    
    
    
44. COLLI A, Besola L, De Caterina R
    Routine left atrial appendage surgical closure for all patients undergoing cardiac surgery?
    Eur Heart J. 2025 Mar 25:ehaf122. doi: 10.1093.
    PubMed    
    
    
    
45. BYRNE RA, Valgimigli M, Bhatt DL, Coughlan JJ, et al
    Great debate: default duration of dual antiplatelet treatment after percutaneous coronary intervention in acute coronary syndrome should be 12 months.
    Eur Heart J. 2025 Mar 8:ehaf070. doi: 10.1093.
    PubMed    
    
    
    
46. CALAFIORE AM, Prapas S, Gaudino M
    Arterial conduits for coronary bypass grafting: the set-point concept.
    Eur Heart J. 2025;46:922-925.
    PubMed     Abstract available
    
    
    
47. BROWN SD, Rodor J, Baker AH
    Targeted approach for next-generation coronary stents.
    Eur Heart J. 2025 Mar 3:ehaf007. doi: 10.1093.
    PubMed    
    
    
    February 2025
48. THELIN S, Modrau IS, Duvernoy O, Dalen M, et al
    No-touch vein grafts in coronary artery bypass surgery: a registry-based randomized clinical trial.
    Eur Heart J. 2025 Feb 19:ehaf018. doi: 10.1093.
    PubMed     Abstract available
    
    
    
49. SPRINGHETTI P, Abdoun K, Dumont E, Dagenais F, et al
    Sex-related differences in prosthesis-patient mismatch after surgical aortic valve replacement and long-term outcomes.
    Eur Heart J. 2025 Feb 18:ehaf076. doi: 10.1093.
    PubMed     Abstract available
    
    
    
50. DE PAULIS R, Chirichilli I, de Kerchove L, Della Corte A, et al
    Current status of aortic valve repair surgery.
    Eur Heart J. 2025 Feb 14:ehaf038. doi: 10.1093.
    PubMed     Abstract available
    
    
    
51. ABDELHAMID M, Abdel Meged AM, Prendergast B, Calvo-Iglesias FE, et al
    Baseline characteristics and outcomes of rheumatic mitral valve disease: the EURObservational Research Programme Valvular Heart Disease II Survey.
    Eur Heart J. 2025 Feb 11:ehaf050. doi: 10.1093.
    PubMed     Abstract available
    
    
    
52. ROMAN M, Miksza J, Lai FY, Sze S, et al
    Revascularization in frail patients with acute coronary syndromes: a retrospective longitudinal study.
    Eur Heart J. 2025;46:535-547.
    PubMed     Abstract available
    
    
    
53. RASMUSSEN LD, Westra J, Karim SR, Dahl JN, et al
    Microvascular resistance reserve: impact on health status and myocardial perfusion after revascularization in chronic coronary syndrome.
    Eur Heart J. 2025;46:424-435.
    PubMed     Abstract available
    
    
    January 2025
54. MATSUMOTO S, Ohno Y, Noda S, Miyamoto J, et al
    Tricuspid regurgitation and outcomes in mitral valve transcatheter edge-to-edge repair.
    Eur Heart J. 2025 Jan 28:ehae924. doi: 10.1093.
    PubMed     Abstract available
    
    
    
55. HOJSGAARD JORGENSEN T, Horsted Thyregod HG, De Backer O
    Coronary revascularization in the NOTION-2 trial: an in-depth data analysis.
    Eur Heart J. 2025 Jan 9:ehae763. doi: 10.1093.
    PubMed    
    
    
    
56. AARTS HM, Voskuil M, Delewi R
    Coronary revascularization in randomized clinical trials comparing transcatheter and surgical aortic valve replacement: is it time to bridge the gap?
    Eur Heart J. 2025 Jan 9:ehae762. doi: 10.1093.
    PubMed    
    
    
    
57. ZHAO Y, Sun J, Lv X
    What truly drives the significant reduction in major adverse cardiac events after switching to electronic cigarettes following percutaneous coronary intervention?
    Eur Heart J. 2025 Jan 8:ehae895. doi: 10.1093.
    PubMed    
    
    
    
58. WILKINSON C, Bhatty A, Batra G, Aktaa S, et al
    Definitions of clinical study outcome measures for cardiovascular diseases: the European Unified Registries for Heart Care Evaluation and Randomized Trials (EuroHeart).
    Eur Heart J. 2025;46:190-214.
    PubMed     Abstract available
    
    
    
59. CREA F
    Challenges with oral anticoagulants: bridging before surgery and concomitant use of non-steroidal anti-inflammatory drugs. Focus on revascularization of ischaemic cardiomyopathy and e-cigarettes after percutaneous coronary intervention.
    Eur Heart J. 2025;46:1-5.
    PubMed    
    
    
    December 2024
60. OKADA T, Kurihara O, Takano M
    Takotsubo syndrome during percutaneous coronary intervention: the role of myocardial ischaemia and microvascular dysfunction in pathophysiology.
    Eur Heart J. 2024 Dec 24:ehae902. doi: 10.1093.
    PubMed    
    
    
    
61. ROFFI M, Montalescot G
    Oral P2Y12 inhibitor pre-treatment for percutaneous coronary intervention in non-ST-elevation acute coronary syndromes: evolving notions in ESC guidelines.
    Eur Heart J. 2024 Dec 4:ehae616. doi: 10.1093.
    PubMed    
    
    
    November 2024
62. OMEROVIC E, Ramunddal T, Petursson P, Angeras O, et al
    Percutaneous vs. surgical revascularization of non-ST-segment elevation myocardial infarction with multivessel disease: the SWEDEHEART registry.
    Eur Heart J. 2024 Nov 27:ehae700. doi: 10.1093.
    PubMed     Abstract available
    
    
    
63. VERGALLO R, Patrono C
    STOPDAPT-3 one-year results support similar efficacy and safety of aspirin and clopidogrel after percutaneous coronary intervention.
    Eur Heart J. 2024 Nov 19:ehae773. doi: 10.1093.
    PubMed    
    
    
    
64. LI Z, Xiang D, Hu K
    Thoracoscopic hypothermic fibrillatory arrest mitral valve replacement for severe mitral regurgitation in Marfan syndrome after Bentall procedure.
    Eur Heart J. 2024 Nov 12:ehae772. doi: 10.1093.
    PubMed    
    
    
    
65. MUNZEL T, Daiber A, Prochaska J
    How quitting, switching to e-cigarettes, or sticking to smoking shapes cardiovascular outcomes after percutaneous coronary intervention.
    Eur Heart J. 2024 Nov 11:ehae756. doi: 10.1093.
    PubMed    
    
    
    October 2024
66. BLOOM JE, Vogrin S, Reid CM, Ajani AE, et al
    Coronary artery bypass grafting vs. percutaneous coronary intervention in severe ischaemic cardiomyopathy: long-term survival.
    Eur Heart J. 2024 Oct 29:ehae672. doi: 10.1093.
    PubMed     Abstract available
    
    
    
67. RHEUDE T, Ruge H, Altaner N, Pellegrini C, et al
    Comparison of strategies for vascular ACCESS closure after transcatheter aortic valve implantation: the ACCESS-TAVI randomized trial.
    Eur Heart J. 2024 Oct 29:ehae784. doi: 10.1093.
    PubMed     Abstract available
    
    
    
68. KANG D, Choi KH, Kim H, Park H, et al
    Prognosis after switching to electronic cigarettes following percutaneous coronary intervention: a Korean nationwide study.
    Eur Heart J. 2024 Oct 21:ehae705. doi: 10.1093.
    PubMed     Abstract available
    
    
    
69. SANDNER S, Antoniades C, Caliskan E, Czerny M, et al
    Intra-operative and post-operative management of conduits for coronary artery bypass grafting: a clinical consensus statement of the European Society of Cardiology Working Group on Cardiovascular Surgery and the European Association for Cardio-Thoraci
    Eur Heart J. 2024 Oct 16:ehae654. doi: 10.1093.
    PubMed     Abstract available
    
    
    
70. 
    Correction to: Great debate: myocardial infarction after cardiac surgery must be redefined.
    Eur Heart J. 2024 Oct 11:ehae734. doi: 10.1093.
    PubMed    
    
    
    September 2024
71. GAUDINO M, Jaffe AS, Milojevic M, Sandoval Y, et al
    Great debate: myocardial infarction after cardiac surgery must be redefined.
    Eur Heart J. 2024 Sep 16:ehae416. doi: 10.1093.
    PubMed    
    
    
    
72. SCHOFER N, Blankenberg S
    Transfemoral or surgical aortic valve replacement in young low-risk patients with tricuspid and bicuspid aortic valve stenosis.
    Eur Heart J. 2024 Sep 5:ehae537. doi: 10.1093.
    PubMed    
    
    
    
73. SATO M, Yoshijima N, Yashima F
    Sinus sequestration due to transcatheter heart valve endothelialization after transcatheter aortic valve replacement.
    Eur Heart J. 2024 Sep 4:ehae606. doi: 10.1093.
    PubMed    
    
    
    
74. PRENDERGAST BD, Patterson T, Redwood S
    Acute coronary occlusion during valve-in-valve TAVI-a shortcut to successful prevention.
    Eur Heart J. 2024;45:3042-3044.
    PubMed    
    
    
    
75. ACKERMANN P, Abdel-Wahab M, Noack T
    Macroscopic findings of severe structural valve deterioration of a transcatheter aortic bioprosthesis.
    Eur Heart J. 2024;45:3092.
    PubMed    
    
    
    
76. MARTINSSON A, Jeppsson A
    Invited editorial on "Outcome of aortic valve replacement versus conservative treatment in asymptomatic patients with severe aortic stenosis - Five years follow-up of the AVATAR randomized controlled trial" by Banovic et al.
    Eur Heart J. 2024 Sep 1:ehae597. doi: 10.1093.
    PubMed    
    
    
    
77. BANOVIC M, Putnik S, Da Costa BR, Penicka M, et al
    Aortic valve replacement versus conservative treatment in asymptomatic severe aortic stenosis: long-term follow-up of the AVATAR trial.
    Eur Heart J. 2024 Sep 1:ehae585. doi: 10.1093.
    PubMed     Abstract available
    
    
    August 2024
78. WATANABE H, Natsuaki M, Morimoto T, Yamamoto K, et al
    Aspirin versus Clopidogrel Monotherapy After Percutaneous Coronary Intervention: 1-Year Follow-up of the STOPDAPT-3 Trial.
    Eur Heart J. 2024 Aug 31:ehae617. doi: 10.1093.
    PubMed     Abstract available
    
    
    
79. DREYFUS J, Juarez-Casso F, Sala A, Carnero-Alcazar M, et al
    Benefit of isolated surgical valve repair or replacement for functional tricuspid regurgitation and long-term outcomes stratified by the TRI-SCORE.
    Eur Heart J. 2024 Aug 30:ehae578. doi: 10.1093.
    PubMed     Abstract available
    
    
    
80. VALGIMIGLI M, Landi A
    Bleeding risk should guide antithrombotic treatment after percutaneous coronary intervention: a Copernican revolution.
    Eur Heart J. 2024 Aug 28:ehae542. doi: 10.1093.
    PubMed    
    
    
    
81. PAVASINI R, Biscaglia S, Kunadian V, Hakeem A, et al
    Coronary artery disease management in older adults: revascularization and exercise training.
    Eur Heart J. 2024;45:2811-2823.
    PubMed     Abstract available
    
    
    
82. SCHELLER B, Zeller T
    Paclitaxel-coated balloons: the more you gain the more you get.
    Eur Heart J. 2024;45:2848-2850.
    PubMed    
    
    
    
83. BAI L, Feng Y, Chen M
    A very rare complication of transcatheter aortic valve replacement.
    Eur Heart J. 2024 Aug 14:ehae316. doi: 10.1093.
    PubMed    
    
    
    
84. PEDICINO D, Vergallo R
    Weekly Journal Scan: Drug-coated balloon for the treatment of in-stent restenosis - the AGENT IDE trial.
    Eur Heart J. 2024;45:2592-2593.
    PubMed    
    
    
    July 2024
85. BESOLA L, Colli A, De Caterina R
    Coronary bypass surgery for multivessel disease after percutaneous coronary intervention in acute coronary syndromes: why, for whom, how early?
    Eur Heart J. 2024 Jul 26:ehae413. doi: 10.1093.
    PubMed     Abstract available
    
    
    
86. KANG J, Yun J, Park KW, Park M, et al
    Long-term outcomes of high bleeding risk patients undergoing percutaneous coronary intervention: a Korean nationwide registry.
    Eur Heart J. 2024 Jul 23:ehae462. doi: 10.1093.
    PubMed     Abstract available
    
    
    
87. CREA F
    Focus on acute myocardial infarction, sex-related differences in coronary bypass surgery, inflammation in heart failure, and infective endocarditis in prosthetic valves.
    Eur Heart J. 2024;45:2463-2467.
    PubMed    
    
    
    
88. CAFORIO ALP, Kaski JP, Gimeno JR, Elliott PM, et al
    Endomyocardial biopsy: safety and prognostic utility in paediatric and adult myocarditis in the European Society of Cardiology EURObservational Research Programme Cardiomyopathy and Myocarditis Long-Term Registry.
    Eur Heart J. 2024;45:2548-2569.
    PubMed     Abstract available
    
    
    
89. ANDREOTTI F, De Caterina R
    Anticoagulation for transient atrial fibrillation post-coronary bypass: high quality evidence needed.
    Eur Heart J. 2024 Jul 16:ehae402. doi: 10.1093.
    PubMed    
    
    
    
90. WANG J, Hu P, Ma XJ
    Mechanical mitral valve obstruction: gone with the wind.
    Eur Heart J. 2024 Jul 16:ehae431. doi: 10.1093.
    PubMed    
    
    
    
91. GARCIA-VILLARREAL OA, Anselmi A, Beurtheret S
    Time is relative, also when comparing transcatheter edge-to-edge repair to mitral valve surgery.
    Eur Heart J. 2024 Jul 10:ehae383. doi: 10.1093.
    PubMed    
    
    
    
92. BERNARD A, Deharo P, Fauchier L
    Time matters when considering treatment for patients with mitral regurgitation.
    Eur Heart J. 2024 Jul 10:ehae384. doi: 10.1093.
    PubMed    
    
    
    
93. DIMITRIADIS K, Pyrpyris N, Tsioufis K
    Long-term outcomes of transcatheter vs. surgical aortic valve replacement: is there still a question to be answered?
    Eur Heart J. 2024 Jul 2:ehae386. doi: 10.1093.
    PubMed    
    
    
    
94. THYREGOD HGH, De Backer O, Sondergaard L
    A notion of bioprosthetic aortic valve durability.
    Eur Heart J. 2024 Jul 2:ehae387. doi: 10.1093.
    PubMed    
    
    
    June 2024
95. HOLFELD J, Nagele F, Polzl L, Engler C, et al
    Cardiac shockwave therapy in addition to coronary bypass surgery improves myocardial function in ischaemic heart failure: the CAST-HF trial.
    Eur Heart J. 2024 Jun 20:ehae341. doi: 10.1093.
    PubMed     Abstract available
    
    
    
96. KOTANIDIS CP, Mills GB, Bendz B, Berg ES, et al
    Invasive vs. conservative management of older patients with non-ST-elevation acute coronary syndrome: individual patient data meta-analysis.
    Eur Heart J. 2024;45:2052-2062.
    PubMed     Abstract available
    
    
    
97. ZHUANG Y, Wang W, Lu F
    Simultaneous transcatheter aortic and tricuspid valve replacement via bilateral cervical approach.
    Eur Heart J. 2024 Jun 12:ehae352. doi: 10.1093.
    PubMed    
    
    
    
98. DOENST T, Faerber G
    Challenge-skill balance in cardiac surgery: an attempt to explain sex-related differences in coronary surgery.
    Eur Heart J. 2024 Jun 11:ehae350. doi: 10.1093.
    PubMed    
    
    
    
99. BEERKENS FJ, Bhatt DL
    Non-ST-elevation acute coronary syndromes with previous coronary artery bypass grafting: is a routine invasive strategy needed?
    Eur Heart J. 2024 Jun 7:ehae287. doi: 10.1093.
    PubMed    
    
    
    
100. CREA F
     Optimizing the treatment of severe aortic stenosis.
     Eur Heart J. 2024;45:1861-1865.
     PubMed    
     
     
     
101. VERGALLO R, Pedicino D
     Weekly Journal Scan: transcatheter aortic valve implantation in patients with small aortic annulus.
     Eur Heart J. 2024 Jun 1:ehae308. doi: 10.1093.
     PubMed    
     
     
     May 2024
102. REN J, Bowyer A, Tian DH, Royse C, et al
     Multiple arterial vs. single arterial coronary artery bypass grafting: sex-related differences in outcomes.
     Eur Heart J. 2024 May 31:ehae294. doi: 10.1093.
     PubMed     Abstract available
     
     
     
103. MARIN-CUARTAS M, Tang GHL, Kiefer P, Fukuhara S, et al
     Transcatheter heart valve explant with infective endocarditis-associated prosthesis failure and outcomes: the EXPLANT-TAVR international registry.
     Eur Heart J. 2024 May 31:ehae292. doi: 10.1093.
     PubMed     Abstract available
     
     
     
104. VAN DE KAR MRD, van Brakel TJ, Van't Veer M, van Steenbergen GJ, et al
     Anticoagulation for post-operative atrial fibrillation after isolated coronary artery bypass grafting: a meta-analysis.
     Eur Heart J. 2024 May 29:ehae267. doi: 10.1093.
     PubMed     Abstract available
     
     
     
105. KELHAM M, Vyas R, Ramaseshan R, Rathod K, et al
     Non-ST-elevation acute coronary syndromes with previous coronary artery bypass grafting: a meta-analysis of invasive vs. conservative management.
     Eur Heart J. 2024 May 28:ehae245. doi: 10.1093.
     PubMed     Abstract available
     
     
     
106. KWON O, Ahn JH, Koh JS, Park Y, et al
     Platelet-fibrin clot strength and platelet reactivity predicting cardiovascular events after percutaneous coronary interventions.
     Eur Heart J. 2024 May 28:ehae296. doi: 10.1093.
     PubMed     Abstract available
     
     
     
107. HARIK L, Gaudino M
     Coronary angiography and bypass surgery: born together and now going separate ways?
     Eur Heart J. 2024;45:1816-1818.
     PubMed    
     
     
     
108. SERRUYS PW, Kageyama S, Pompilio G, Andreini D, et al
     Coronary bypass surgery guided by computed tomography in a low-risk population.
     Eur Heart J. 2024;45:1804-1815.
     PubMed     Abstract available
     
     
     
109. ROFFI M, Meier B, Gallino A
     Fifty years of percutaneous transluminal angioplasty.
     Eur Heart J. 2024;45:1779-1780.
     PubMed    
     
     
     
110. DVIR D, Tchetche D, Leon MB, Genereux P, et al
     Leaflet modification before transcatheter aortic valve implantation in patients at risk for coronary obstruction: the ShortCut study.
     Eur Heart J. 2024 May 15:ehae303. doi: 10.1093.
     PubMed     Abstract available
     
     
     
111. JORGENSEN TH, Thyregod HGH, Savontaus M, Willemen Y, et al
     Transcatheter Aortic Valve Implantation in Low-Risk Tricuspid or Bicuspid Aortic Stenosis: The NOTION-2 Trial.
     Eur Heart J. 2024 May 15:ehae331. doi: 10.1093.
     PubMed     Abstract available
     
     
     
112. PAOLUCCI L, Mangiacapra F, Sergio S, Nusca A, et al
     Periprocedural myocardial infarction after percutaneous coronary intervention and long-term mortality: a meta-analysis.
     Eur Heart J. 2024 May 14:ehae266. doi: 10.1093.
     PubMed     Abstract available
     
     
     
113. VERGALLO R, Patrono C
     Weekly journal scan: intravascular imaging to guide percutaneous coronary intervention-ready for prime time?
     Eur Heart J. 2024 May 4:ehae242. doi: 10.1093.
     PubMed    
     
     
     April 2024
114. PIBAROT P
     Transcatheter aortic valve replacement: benchmarking practices to optimize quality and outcomes.
     Eur Heart J. 2024 Apr 26:ehae174. doi: 10.1093.
     PubMed    
     
     
     
115. KIM YY, Lluri G, Haeffele C, Daugherty T, et al
     Hepatocellular carcinoma in survivors after Fontan operation: a case-control study.
     Eur Heart J. 2024;45:1477-1480.
     PubMed    
     
     
     
116. VERGALLO R, Galiuto L
     Weekly journal scan: angina severity reduced by percutaneous coronary intervention in the ORBITA-2 trial.
     Eur Heart J. 2024 Apr 10:ehae215. doi: 10.1093.
     PubMed    
     
     
     
117. BLEIZIFFER S
     Transcatheter vs. surgical treatment of aortc stenosis: long awaited long-term data, yet a long way to go.
     Eur Heart J. 2024;45:1125-1126.
     PubMed    
     
     
     
118. WINDECKER S, Gilard M, Achenbach S, Cribier A, et al
     Device innovation in cardiovascular medicine: a report from the European Society of Cardiology Cardiovascular Round Table.
     Eur Heart J. 2024;45:1104-1115.
     PubMed     Abstract available
     
     
     
119. WAYDA B
     Machine perfusion of marginal donor hearts: a valuable tool, but where and for whom?
     Eur Heart J. 2024;45:1178.
     PubMed    
     
     
     
120. AMESZ JH, Taverne YJHJ, Manintveld OC
     To transplant or not to transplant 'marginal' donor hearts: is machine perfusion the answer?
     Eur Heart J. 2024;45:1177.
     PubMed    
     
     
     March 2024
121. FRANK D, Durand E, Lauck S, Muir DF, et al
     A streamlined pathway for transcatheter aortic valve implantation: the BENCHMARK study.
     Eur Heart J. 2024 Mar 30:ehae147. doi: 10.1093.
     PubMed     Abstract available
     
     
     
122. BAKAR SN, Ong G, Fam NP
     LuX-Valve Plus transcatheter tricuspid valve replacement for massive tricuspid flail after lead extraction.
     Eur Heart J. 2024 Mar 29:ehae165. doi: 10.1093.
     PubMed    
     
     
     
123. 
     Correction to: Healthcare resource utilisation and safety outcomes in patients undergoing transcatheter mitral valve repair - A nationwide analysis.
     Eur Heart J. 2024 Mar 25:ehae168. doi: 10.1093.
     PubMed    
     
     
     
124. BAX JJ, Hahn RT, Marsan NA, Baumgartner H, et al
     Great debate: symptomatic moderate aortic stenosis should undergo intervention.
     Eur Heart J. 2024 Mar 6:ehae050. doi: 10.1093.
     PubMed    
     
     
     
125. MARTINSSON A, Rasalingam R, Jeppsson A
     Stable incidence and outcomes for patients with incident aortic stenosis: how can we translate excellent trial data into improved clinical outcomes in the population?
     Eur Heart J. 2024 Mar 6:ehae078. doi: 10.1093.
     PubMed    
     
     
     
126. URSO S, Sadaba R, Dayan V
     Benefits of coronary artery bypass grafting over percutaneous coronary intervention in left main disease: the strength of the evidence.
     Eur Heart J. 2024 Mar 5:ehae135. doi: 10.1093.
     PubMed    
     
     
     
127. SUDO K, Nakamura K, Sato A
     Usefulness of endomyocardial biopsy using three-dimensional delivery system for the diagnosis of cardiac amyloidosis with complete atrioventricular block after transcatheter aortic valve implantation.
     Eur Heart J. 2024 Mar 5:ehae137. doi: 10.1093.
     PubMed    
     
     
     
128. MEHILLI J
     Shortening in-hospital stay after transcatheter aortic valve implantation: a deja vu in percutaneous interventions.
     Eur Heart J. 2024 Mar 4:ehae096. doi: 10.1093.
     PubMed    
     
     
     
129. DURAND E, Beziau-Gasnier D, Michel M, Iung B, et al
     Reducing length of stay after transfemoral transcatheter aortic valve implantation: the FAST-TAVI II trial.
     Eur Heart J. 2024 Mar 4:ehae081. doi: 10.1093.
     PubMed     Abstract available
     
     
     
130. MAISANO F, Hahn R, Sorajja P, Praz F, et al
     Transcatheter treatment of the tricuspid valve: current status and perspectives.
     Eur Heart J. 2024 Mar 1:ehae082. doi: 10.1093.
     PubMed     Abstract available
     
     
     February 2024
131. LURZ P, Kresoja KP
     Surgical or percutaneous treatment of mitral regurgitation: clip or cut?
     Eur Heart J. 2024 Feb 21:ehae084. doi: 10.1093.
     PubMed    
     
     
     
132. NISHIHIRA K, Asano Y, Shibata Y
     Efficacy of paclitaxel-coated balloon angioplasty combined with intensive lipid-lowering therapy for ST-segment elevation myocardial infarction: insights from near-infrared spectroscopy.
     Eur Heart J. 2024 Feb 15:ehae073. doi: 10.1093.
     PubMed    
     
     
     
133. THYREGOD HGH, Jorgensen TH, Ihlemann N, Steinbruchel DA, et al
     Transcatheter or surgical aortic valve implantation: 10-year outcomes of the NOTION trial.
     Eur Heart J. 2024 Feb 7:ehae043. doi: 10.1093.
     PubMed     Abstract available
     
     
     January 2024
134. DEHARO P, Obadia JF, Guerin P, Cuisset T, et al
     Mitral transcatheter edge to edge repair versus isolated mitral surgery for severe mitral regurgitation: A French nationwide study.
     Eur Heart J. 2024 Jan 19:ehae046. doi: 10.1093.
     PubMed     Abstract available
     
     
     
135. HAUSLEITER J, Lachmann M, Stolz L, Bedogni F, et al
     Artificial intelligence-derived risk score for mortality in secondary mitral regurgitation treated by transcatheter edge-to-edge repair: the EuroSMR risk score.
     Eur Heart J. 2024 Jan 19:ehad871. doi: 10.1093.
     PubMed     Abstract available
     
     
     
136. VERGALLO R, Galiuto L
     Targeting inflammation with colchicine does not prevent atrial fibrillation after major non-cardiac thoracic surgery.
     Eur Heart J. 2024 Jan 18:ehae006. doi: 10.1093.
     PubMed    
     
     
     
137. BENFARI G, Essayagh B, Michelena HI, Ye Z, et al
     Severe aortic stenosis: secular trends of incidence and outcomes.
     Eur Heart J. 2024 Jan 8:ehad887. doi: 10.1093.
     PubMed     Abstract available
     
     
     December 2023
138. LI XM, Zhu XJ, Jing ZC
     Reverse cardiac remodelling after balloon atrial septostomy for pulmonary arterial hypertension and end-stage heart failure.
     Eur Heart J. 2023 Dec 16:ehad822. doi: 10.1093.
     PubMed    
     
     
     November 2023
139. LU ZN, Yang Y, Song G
     A patient-tailored clipping strategy of transcatheter edge-to-edge repair as salvage for cardiogenic shock complicated by mitral valve cleft and bileaflet flails.
     Eur Heart J. 2023 Nov 29:ehad802. doi: 10.1093.
     PubMed    
     
     
     September 2023
140. BEYGUI F, Guillemot V, Saloux E
     Complex mitral para-prosthetic leak closure as a bridge to heart transplant.
     Eur Heart J. 2023 Sep 28:ehad602. doi: 10.1093.
     PubMed    
     
     

Thank you for your interest in scientific medicine.

AMEDEO Thoracic Surgery is free of charge.